研究单位：[1]Fuwai Hospital, China National Center for Cardiovascular Diseases[2]Peking University Third Hospital[3]Beijing Chao Yang Hospital[4]Xuanwu Hospital, Beijing[5]Beijing Friendship Hospital
In ASCVD patients complicated with subclinical hypothyroidism, the percentage of those who did not reach the target of lipid-lowering therapy (LDL-C>1.8mmol/L) is usually higher than that in population with normal thyroid function. The present study aims to randomly compare two lipid-lowering therapeutic strategies (statins only vs. statins combined with thyroid hormone supplement).
